Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Aytekin Oto

University of Chicago, Department: Radiation Diagnostic/oncology

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

QMIS, LLC

Disclosed Value
Listed Reason
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)

Aytekin Oto, MD, is co-founder along with his Co-PI on the above grant, Gregory Karczmar, PhD of the new, privately-held startup company QMIS, LLC. This aim of this company is to develop hybrid MR techniques and risk-based imaging software. Because the business interests of QMIS, LLC overlap with the overall aims of this R01, the University has determined that a financial conflict of interest exists that must be managed in relation to this research.

Listed Research Project
Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI

NARRATIVE There is a critical need for new alternatives for screening and diagnosis of prostate cancer (PCa). MRI has potential to improve detection and management of PCa, due to its excellent soft tissue contrast and functional information, but no current clinical MRI method is adequate for routine screening. Here we propose to develop hybrid multi-dimensional MRI (HM-MRI), based on quantitative measurements of the interdependence of T2 and ADC, to significantly increase the accuracy of PCa diagnosis.

Filed on June 17, 2019.

Tell us what you know about Aytekin Oto's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page